Galantamine Slows Down Plaque Formation and Behavioral Decline in the 5XFAD Mouse Model of Alzheimer’s Disease
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Galantamine Slows Down Plaque Formation and Behavioral Decline in the 5XFAD Mouse Model of Alzheimer’s Disease
Authors
Keywords
-
Journal
PLoS One
Volume 9, Issue 2, Pages e89454
Publisher
Public Library of Science (PLoS)
Online
2014-02-22
DOI
10.1371/journal.pone.0089454
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Acetylcholinesterase inhibitors as Alzheimer therapy: From nerve toxins to neuroprotection
- (2013) Manjinder Singh et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Lysosomal NEU1 deficiency affects amyloid precursor protein levels and amyloid-β secretion via deregulated lysosomal exocytosis
- (2013) Ida Annunziata et al. Nature Communications
- Comprehensive behavioral characterization of an APP/PS-1 double knock-in mouse model of Alzheimer's disease
- (2013) Scott J Webster et al. Alzheimers Research & Therapy
- Sensorimotor gating and memory deficits in an APP/PS1 double transgenic mouse model of Alzheimer's disease
- (2012) Hongxing Wang et al. BEHAVIOURAL BRAIN RESEARCH
- Investigating the binding interactions of galantamine with β-amyloid peptide
- (2012) Praveen P.N. Rao et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A truncated peptide from p35, a Cdk5 activator, prevents Alzheimer's disease phenotypes in model mice
- (2012) Varsha Shukla et al. FASEB JOURNAL
- Alzheimer's Disease, Oestrogen and Mitochondria: an Ambiguous Relationship
- (2012) Amandine Grimm et al. MOLECULAR NEUROBIOLOGY
- Accelerated cortical atrophy in cognitively normal elderly with high -amyloid deposition
- (2012) G. Chetelat et al. NEUROLOGY
- A Plaque-Specific Antibody Clears Existing β-amyloid Plaques in Alzheimer's Disease Mice
- (2012) Ronald B. DeMattos et al. NEURON
- APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD)
- (2012) R. Lalonde et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Weight loss and Alzheimer's disease: temporal and aetiologic connections
- (2012) Giuseppe Sergi et al. PROCEEDINGS OF THE NUTRITION SOCIETY
- Galantamine and behavior in Alzheimer disease: analysis of four trials
- (2011) S. Kavanagh et al. ACTA NEUROLOGICA SCANDINAVICA
- Astrocytes: Implications for Neuroinflammatory Pathogenesis of Alzheimers Disease
- (2011) Chuanyu Li et al. Current Alzheimer Research
- Combination Therapy for Alzheimerʼs Disease
- (2011) Laxeshkumar Patel et al. DRUGS & AGING
- The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
- (2011) Eric Karran et al. NATURE REVIEWS DRUG DISCOVERY
- The noradrenaline precursor L-DOPS reduces pathology in a mouse model of Alzheimer's disease
- (2011) Sergey Kalinin et al. NEUROBIOLOGY OF AGING
- Galantamine treatment in Alzheimer's disease: response and long-term outcome in a routine clinical setting
- (2011) Åsa Wallin et al. Neuropsychiatric Disease and Treatment
- Amyloid-β associated cortical thinning in clinically normal elderly
- (2010) J. Alex Becker et al. ANNALS OF NEUROLOGY
- Galantamine for Alzheimer's disease
- (2010) David Prvulovic et al. Expert Opinion on Drug Metabolism & Toxicology
- Identification of Low Molecular Weight Pyroglutamate Aβ Oligomers in Alzheimer Disease
- (2010) Oliver Wirths et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Galantamine-induced Amyloid-β Clearance Mediated via Stimulation of Microglial Nicotinic Acetylcholine Receptors
- (2010) Kazuyuki Takata et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Alzheimer's disease: strategies for disease modification
- (2010) Martin Citron NATURE REVIEWS DRUG DISCOVERY
- Regional differences in MRI detection of amyloid plaques in AD transgenic mouse brain
- (2010) T.M. Wengenack et al. NEUROIMAGE
- Memogain is a Galantamine Pro-drug having Dramatically Reduced Adverse Effects and Enhanced Efficacy
- (2009) Alfred Maelicke et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Galantamine inhibits β-amyloid aggregation and cytotoxicity
- (2009) Balpreet Matharu et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- COL25A1 triggers and promotes Alzheimer’s disease-like pathology in vivo
- (2009) Ying Tong et al. NEUROGENETICS
- Oligomeric amyloid associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques
- (2009) R. M. Koffie et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer's disease–like pathology
- (2008) Stephan Schilling et al. NATURE MEDICINE
- Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model
- (2008) Ryoichi Kimura et al. NEUROBIOLOGY OF DISEASE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now